Drug major Sun Pharma said its board will meet later this week to consider internal restructuring of the business and to announce first quarter results.
The Mumbai-headquartered firm said in a filing to the BSE that its board on 10 August “would consider the internal restructuring of the business of the company with effect from 31 March, 2012″.
.Shares of Sun Pharma were trading at Rs 670.30 on the BSE in the afternoon trade. Reuters
The board will also announce the financial results of the company for the first quarter ended 30 June, 2012. The board would also consider declaration of the interim dividend of Rs 4.25 per share of Re 1 each on equity shares of the company for the year ended March 31, 2012, the filing said.
Shares of Sun Pharma were trading at Rs 670.30 on the BSE in the afternoon trade, up 1.55 percent from its previous close.
Firstpost encourages open discussion and debate, but please adhere to the rules below, before posting. Comments that are found to be in violation of any one or more of the guidelines will be automatically deleted:
Personal attacks/name calling will not be tolerated. This applies to comments directed at the author, other commenters and other politicians/public figures
Please do not post comments that target a specific community, caste, nationality or religion.
While you do not have to use your real name, any commenters using any Firstpost writer's name will be deleted, and the commenter banned from participating in any future discussions.
Comments will be moderated for abusive and offensive language.